Drawing for DOXISOME

USPTO serial 77604290

DOXISOME

Reviewed by CopyMark Law Group

Reg. 3631124Status 710
Filing date
Status date
Registration date
Jun 2, 2009
Examiner
DAHLING, KRISTIN M
Law office
TMO LAW OFFICE 113

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with DOXISOME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joe McKinney Muncy

Joe McKinney Muncy Muncy, Geissler, Olds & Lowe, P.C.4000 Legato RoadSuite 310Fairfax, VA 22033

Goods and services

ClassDescriptionStatusFirst use
005Antibacterial pharmaceuticals; antibacterial substances for medical purposes; antibiotic preparations; antibiotics; antimicrobials for dermatologic use; antiseptic preparations; antiseptics; anti-cancer preparations; bactericides; bacteriostats for medicinal, dental and veterinary use; chemotherapeutics; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancers; pharmaceutical preparations for the prevention of cancers; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti- infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancers; reagents for medical use; tumor suppressing agentsSECTION 8 - CANCELLEDOct 6, 2008

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 3, 2020CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Jun 2, 2018REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Nov 13, 2014NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Nov 13, 2014C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Nov 13, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 29, 2014E815TEAS SECTION 8 & 15 RECEIVED—
Jun 2, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 17, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 25, 2009NPUBNOTICE OF PUBLICATION—
Feb 11, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 11, 2009ALIEASSIGNED TO LIE—
Feb 2, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 1, 2009DOCKASSIGNED TO EXAMINER—
Nov 3, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance